Dataset DZNE-2025-01407

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Dataset: RNA Selectively Modulates Activity of Virulent Amyloid PSMα3 and Host Defense LL-37 via Phase Separation and Aggregation Dynamics, v1

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2025
Zenodo

Zenodo () [10.5281/zenodo.17113344]

This record in other databases:  

Please use a persistent id in citations: doi:  doi:

Abstract: Amyloids, classically linked to neurodegenerative diseases, also play critical roles in infection and immunity. Phenol-soluble modulins (PSMs) from Staphylococcus aureus are virulent amyloids that contribute to cytotoxicity, immune modulation, and biofilm stability. PSMα3 forms cross-α amyloid fibrils and shares sequence and structural features with LL-37, a human host-defense peptide that assembles into α-helical structures. Here, we uncover RNA as a potent, context-dependent modulator of their aggregation and activity. RNA consistently reduces LL-37’s cytotoxicity toward human cells without compromising its antibacterial function, suggesting a selective host-protective mechanism. In contrast, RNA preserves PSMα3’s cytotoxic and antimicrobial activity over time, likely by promoting liquid–liquid phase separation (LLPS) and stabilizing bioactive fibrillar polymorphs, enabling S. aureus to fine-tune its virulence strategies. At higher concentrations, RNA drives both peptides toward distinct aggregated states, amorphous for LL-37 and fibrillar for PSMα3, underlying their divergent functional outcomes. The amyloid inhibitor EGCG abolishes the bioactivity of both PSMα3 and LL-37, overriding RNA’s modulatory effects. Together, our findings establish RNA as a key modulator of both virulent amyloids and host-defense peptides, with broad implications for microbial immune evasion, innate immunity, and amyloid-associated diseases. Moreover, they highlight phase transitions as a tunable mechanism for regulating peptide bioactivity and a promising therapeutic target across infectious and neurodegenerative conditions.


Contributing Institute(s):
  1. Translational Structural Biology (AG Zweckstetter)
Research Program(s):
  1. 352 - Disease Mechanisms (POF4-352) (POF4-352)

Appears in the scientific report 2025
Click to display QR Code for this record

The record appears in these collections:
Institute Collections > GÖ DZNE > GÖ DZNE-AG Zweckstetter
Document types > Other Resources > Datasets
Public records
Publications Database

 Record created 2025-12-17, last modified 2025-12-18



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)